Glenmede Trust’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-500
| Closed | -$4K | – | 2548 |
|
|
2020
Q3 | $4K | Buy |
500
+279
| +126% | +$2.23K | ﹤0.01% | 2170 |
|
|
2020
Q2 | $1K | Sell |
221
-103
| -32% | -$466 | ﹤0.01% | 2423 |
|
|
2020
Q1 | $3K | Hold |
324
| – | – | ﹤0.01% | 2828 |
|
|
2019
Q4 | $3K | Hold |
324
| – | – | ﹤0.01% | 2828 |
|
|
2019
Q3 | $3 | Buy |
324
+110
| +51% | +$1 | ﹤0.01% | 2812 |
|
|
2019
Q2 | $2 | Hold |
214
| – | – | ﹤0.01% | 2901 |
|
|
2019
Q1 | $2 | Sell |
214
-64
| -23% | -$1 | ﹤0.01% | 2877 |
|
|
2018
Q4 | $4 | Buy |
+278
| New | +$4 | ﹤0.01% | 2629 |
|
|
2018
Q2 | – | Sell |
-338
| Closed | -$4K | – | 2437 |
|
|
2018
Q1 | $4K | Hold |
338
| – | – | ﹤0.01% | 2487 |
|
|
2017
Q4 | $4K | Hold |
338
| – | – | ﹤0.01% | 2487 |
|
|
2017
Q3 | $6K | Hold |
338
| – | – | ﹤0.01% | 2325 |
|
|
2017
Q2 | $7K | Hold |
338
| – | – | ﹤0.01% | 2217 |
|
|
2017
Q1 | $7K | Sell |
338
-871,701
| -100% | -$18.1M | ﹤0.01% | 2217 |
|
|
2016
Q4 | $30.3M | Sell |
872,039
-181,284
| -17% | -$6.31M | 0.17% | 218 |
|
|
2016
Q3 | $25.8M | Sell |
1,053,323
-1,981
| -0.2% | -$48.6K | 0.15% | 249 |
|
|
2016
Q2 | $25.2M | Buy |
1,055,304
+388,141
| +58% | +$9.28M | 0.15% | 237 |
|
|
2016
Q1 | $15.6M | Buy |
667,163
+47,997
| +8% | +$1.12M | 0.1% | 289 |
|
|
2015
Q4 | $18.7M | Buy |
619,166
+34,604
| +6% | +$1.04M | 0.13% | 264 |
|
|
2015
Q3 | $23.2M | Buy |
584,562
+127,050
| +28% | +$5.05M | 0.17% | 198 |
|
|
2015
Q2 | $31.6M | Sell |
457,512
-161,127
| -26% | -$11.1M | 0.23% | 131 |
|
|
2015
Q1 | $33.8M | Buy |
618,639
+307,744
| +99% | +$16.8M | 0.25% | 107 |
|
|
2014
Q4 | $13.2M | Buy |
+310,895
| New | +$13.2M | 0.1% | 292 |
|
|
2014
Q1 | – | Sell |
-19,456
| Closed | -$472K | – | 2407 |
|
|
2013
Q4 | $472K | Hold |
19,456
| – | – | ﹤0.01% | 873 |
|
|
2013
Q3 | $417K | Hold |
19,456
| – | – | 0.01% | 869 |
|
|
2013
Q2 | $432K | Buy |
+19,456
| New | +$432K | 0.01% | 817 |
|